Search results
Metformin: Treatment for Newly Diagnosed Type 2 Diabetes
Healthline· 5 days agoMetformin is particularly effective for people with diabetes or prediabetes who have obesity and...
Diabetes: Could eating avocado help lower the risk of this condition?
Medical News Today· 16 hours agoAvocados are rich in fiber, antioxidants, and healthy fats that can support metabolic health and...
Are Investors Undervaluing Tandem Diabetes Care, Inc. (NASDAQ:TNDM) By 31%?
Simply Wall St. via Yahoo Finance· 7 hours agoKey Insights Tandem Diabetes Care's estimated fair value is US$50.92 based on 2 Stage Free Cash Flow...
Eating more avocados could lower risk of Type 2 diabetes in women, study says
CBS News· 4 hours agoA new study looked at whether or not eating more avocados could help people stave off Type 2 ...
Why Your Breakfast Should Start with a Vegetable
Time via Yahoo News· 7 hours agoThe source of that blood sugar was sweet foods, grains, and other carbohydrates. She says she thought about them every 30 seconds, leading to constant...
Diabetes Expo held in Lexington
WKYT Lexington· 13 hours agoThe University of Kentucky Cooperative Extension Office was a buzz this weekend as folks gathered for the 2nd annual Diabetes Expo. According to the...
Food Emulsifiers Linked to Increased Type 2 Diabetes Risk
Technology Networks· 5 days agoEmulsifiers in ultra-processed foods may increase the chance of developing type 2 diabetes,...
Raising awareness and money to end type 1 diabetes
Omaha World-Herald· 9 hours agoJill Conway was 10 years old when she was diagnosed with type 1 diabetes, or T1D, a disease that, without warning, strikes the body’s immune system. Like...
Novo Nordisk: Growth Is Still A Better Choice
GuruFocus.com via Yahoo Finance· 12 hours agoNovo Nordisk A/S (NYSE:NVO) is the largest Danish pharmaceutical company focusing on developing medicines to combat obesity, diabetes, cardiovascular...
How expanded use of GLP-1s could affect long-term outlooks for Eli Lilly and Novo Nordisk
Yahoo Finance via AOL· 6 hours agoJust a few short years after coming to market, the latest GLP-1 drugs are showing versatility in...